Major VDCs will be examined such as:
Virus-induced cancers in Asia account for over 60% of global VDCs, and are still expected to increase in incidence. The VICTORY consortium harnesses unique, competitive capabilities and resources across academic institutions and industry to establish:
The VICTORY consortium creates an unprecedented, coordinated, leading global centre of VDC excellence embracing the biomedical, academic healthcare, and industry sectors.
Subscribe to our mailing list to get the updates to your email inbox...
30 Hospital Boulevard, 168583 +65 6436 8000